Robert A. Morse Jr. - 04 Apr 2023 Form 4 Insider Report for ProPhase Labs, Inc. (PRPH)

Reporting relationship: CHIEF FINANCIAL OFFICER
Issuer ticker: PRPH
Reported as of: 04 Apr 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Apr 2023, 16:20:35 UTC
Prior SEC filing: 13 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Robert Morse

Key filing fact

Robert A. Morse Jr. filed Form 4 for ProPhase Labs, Inc. (PRPH) on 06 Apr 2023.

Key facts

This page summarizes Robert A. Morse Jr.'s Form 4 filing for ProPhase Labs, Inc. (PRPH).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Apr 2023, 16:20.

Change

Previous filing in this sequence was filed on 13 Jan 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRPH transaction Derivative

Option (right to buy)

Award

Transaction value: $0
Shares: +50,000
Change %
Price: $0.000000
Shares after: 50,000
Date: 04 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $9.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that will vest in five equal annual installments beginning April 5, 2024, subject to the Reporting Person's continued employment with the Issuer on each vesting date.